These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28215414)

  • 1. Meta-Analysis of Comparison of Drug-Eluting Stents and Bare-Metal Stents in Patients on Dialysis.
    Li S; Ye D; Chen G; Xu W
    Am J Cardiol; 2017 Apr; 119(8):1186-1192. PubMed ID: 28215414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stents in patients with end-stage renal disease: meta-analysis and systematic review of the literature.
    Abdel-Latif A; Mukherjee D; Mesgarzadeh P; Ziada KM
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):942-8. PubMed ID: 20506492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
    Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting compared to bare metal stents in patients with end-stage renal disease on dialysis: a meta-analysis.
    Galiffa VA; Crimi G; Gritti V; Scotti V; Ferrario M; Repetto A; Ferlini M; Marinoni B; De Ferrari GM; De Servi S; Sante Bongo A; Oltrona Visconti L; Klersy C
    J Cardiovasc Med (Hagerstown); 2019 May; 20(5):313-320. PubMed ID: 30921269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of dialysis patients after implantation of DES: meta analysis and systematic review of literature.
    Athappan G; Ponniah T
    Minerva Cardioangiol; 2009 Jun; 57(3):291-7. PubMed ID: 19513010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis.
    Chang TI; Montez-Rath ME; Tsai TT; Hlatky MA; Winkelmayer WC
    J Am Coll Cardiol; 2016 Mar; 67(12):1459-1469. PubMed ID: 27012407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
    Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
    Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected].
    Philip F; Agarwal S; Bunte MC; Goel SS; Tuzcu EM; Ellis S; Kapadia SR
    Circ Cardiovasc Interv; 2014 Feb; 7(1):49-61. PubMed ID: 24280964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on Dialysis: A Systematic Review and Meta-Analysis.
    Khera S; Villablanca PA; Kolte D; Gupta T; Hasan Khan M; Velagapudi P; Kalra A; Kleiman N; Aronow HD; Abbott JD; Rosenfield K; Drachman DE; Bangalore S; Bhatt DL; Naidu SS
    Cardiol Rev; 2018; 26(6):277-286. PubMed ID: 30157064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bare-metal stent versus drug-eluting stent in large coronary arteries: meta-analysis of randomized controlled trials.
    Geng DF; Meng Z; Yan HY; Nie RQ; Deng J; Wang JF
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1087-94. PubMed ID: 22899538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
    Barthelemy O; Helft G; Silvain J; Bellemain-Appaix A; Beygui F; Choussat R; Berman E; Collet JP; Montalescot G; Metzger JP; Le Feuvre C
    Arch Cardiovasc Dis; 2011 Dec; 104(12):604-10. PubMed ID: 22152512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.
    Jones DA; Rathod KS; Gallagher S; Weerackody R; Knight CJ; Rothman MT; Mathur A; Jain AK; Timmis AD; Wragg A
    Catheter Cardiovasc Interv; 2013 May; 81(6):E237-44. PubMed ID: 22707383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of drug-eluting versus bare-metal stents in patients with calcified coronary lesions: a meta-analysis.
    Zhang BC; Wang C; Li WH; Li DY
    Intern Med J; 2015 Feb; 45(2):203-11. PubMed ID: 25370798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.
    Kirtane AJ; Gupta A; Iyengar S; Moses JW; Leon MB; Applegate R; Brodie B; Hannan E; Harjai K; Jensen LO; Park SJ; Perry R; Racz M; Saia F; Tu JV; Waksman R; Lansky AJ; Mehran R; Stone GW
    Circulation; 2009 Jun; 119(25):3198-206. PubMed ID: 19528338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Eluting Stents Versus Bare-Metal Stents in Patients With End-Stage Renal Disease.
    Wang Y; Zhu S; Gao P; Chen Y; Zhang Q
    Am J Med Sci; 2018 Apr; 355(4):331-341. PubMed ID: 29661346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.